Article
Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?
Autoimmunity reviews - 1 Sept 2015
De Carolis S, Botta A, Salvi S, di Pasquo E, Del Sordo G, Garufi C, Lanzone A, De Carolis M P
Abstract excerpt
The best therapy regimen for refractory obstetrical antiphospholipid syndrome remains to be determined. Additional treatments with steroids, plasma exchanges and immunoglobulins failed to show any beneficial effect. We present a case of a woman who had a better pregnancy outcome after the administration of hydroxychloroquine (HCQ) as additional treatment. Furthermore, we highlighted that HCQ was able to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.